Hormone receptor-positive (ER/PR+), defined as ≥1% estrogen receptor (ER) and/or ≥1% progesterone receptor (PR) expression by immunohistochemistry (IHC), accounts for approximately 70% of BC [1]. This evidence concerns the gene PGR and breast cancer.